GSK and Alector collaborate on Alzheimer’s and Parkinson’s treatments
Fortune - 02-Jul-2021The $2.2 billion deal will focus on immune-based therapies for neurodegenerative diseases
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Author at Financial Times
Suzi Ring is a prominent legal correspondent for the Financial Times based in London. She covers topics such as white-collar crime, antitrust issues, and the business of law, and also co-writes the FT's "Full Disclosure" newsletter. Prior to joining FT, Suzi spent a decade at Bloomberg News, where she reported on healthcare, Brexit, and legal affairs. Her work often sheds light on significant regulatory matters and corporate legal issues
Visit website: https://fortune.com/author/suzi-ring/
See alsoDetails last updated 16-Nov-2024
The $2.2 billion deal will focus on immune-based therapies for neurodegenerative diseases